Point72 Asset Management L.P. raised its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 105.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,756,122 shares of the biopharmaceutical company’s stock after acquiring an additional 1,413,722 shares during the […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]
Bellevue Group AG decreased its position in Verona Pharma plc (NASDAQ:VRNA – Free Report) by 1.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 839,996 shares of the company’s stock after selling 16,362 shares during the period. Bellevue Group AG owned about 1.05% of Verona Pharma […]
Crestline Management LP lowered its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 5.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,660,732 shares of the company’s stock after selling 300,000 shares during the period. Denali Therapeutics makes up 10.3% of Crestline Management LP’s holdings, making the stock its biggest position. […]